Symbols / PIRS
PIRS Chart
About
No company description available for this symbol.
Fundamentals
Scroll to Statements| Sector | — | Industry | — | Market Cap | — |
| Enterprise Value | — | Income | — | Sales | — |
| Book/sh | — | Cash/sh | — | Dividend Yield | — |
| Payout | — | Employees | — | IPO | — |
| P/E | — | Forward P/E | — | PEG | — |
| P/S | — | P/B | — | P/C | — |
| EV/EBITDA | — | EV/Sales | — | Quick Ratio | — |
| Current Ratio | — | Debt/Eq | — | LT Debt/Eq | — |
| EPS (ttm) | — | EPS next Y | — | EPS Growth | — |
| Revenue Growth | — | Earnings | 2023-11-14 16:00 | ROA | — |
| ROE | — | ROIC | — | Gross Margin | — |
| Oper. Margin | — | Profit Margin | — | Shs Outstand | — |
| Shs Float | — | Short Float | — | Short Ratio | — |
| Short Interest | — | 52W High | — | 52W Low | — |
| Beta | — | Avg Volume | — | Volume | — |
| Target Price | — | Recom | — | Prev Close | — |
| Price | — | Change | — |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
—
Mean price target
2. Current target
—
Latest analyst target
3. DCF / Fair value
—
Simplified FCF or EPS-based estimate
Ratings
No analyst ratings or price targets available.
- Pieris Pharmaceuticals Announces Merger and Share Increase - Nasdaq hu, 12 Dec 2024 08
- Pieris Pharmaceuticals: What a Delisting Biotech Still Signals for Risk?Hungry Traders - AD HOC NEWS ue, 17 Feb 2026 17
- Is Pieris Pharmaceuticals (PIRS) a Value Trap? A Comprehensive Analysis - Yahoo Finance hu, 24 Aug 2023 07
- YieldBoost CVS Health From 3.5% To 6.4% Using Options - Nasdaq Wed, 01 Oct 2025 07
- Do Institutions Own Shares In Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS)? - simplywall.st Wed, 26 Jun 2019 07
- Pieris Pharmaceuticals closes $51m public offering - Drug Delivery Business Wed, 21 Feb 2018 08
- Pieris Pharmaceuticals (PIRS) Stock Price, News & Analysis $PIRS - MarketBeat Fri, 12 Aug 2016 11
- Six in 10 Korean households own homes while youth and newlyweds face worsening housing conditions - CHOSUNBIZ - Chosunbiz Sun, 16 Nov 2025 08
- PIRS: In Vivo Preclinical Data on PRS-343 to be Presented at AACR 2016… - Zacks Small Cap Research Wed, 31 Mar 2021 02
- Optimizing ALL Treatment Through Guideline Adherence and Highly-Effective Therapies - AJMC hu, 30 Oct 2025 07
- StockWatch: Abcam, Founder Spar over Company’s Future - GEN - Genetic Engineering and Biotechnology News Fri, 23 Jun 2023 07
- Up 1,000% in 5 Years? These Healthcare Stocks Could Pull It Off. - The Motley Fool Fri, 04 Mar 2022 08
- Italy ties tax breaks on venture capital returns to share of allocated assets - Investment & Pensions Europe Mon, 23 Dec 2024 08
- Pieris Pharmaceuticals Announces 1-for-80 Reverse Stock Split - Yahoo Finance Fri, 19 Apr 2024 07
- PIR's Bryan Sperber has had eventful presidency - The Arizona Republic Fri, 17 Mar 2017 07
Insider Transactions
No recent insider transactions.
Financials
No financial statements available. Data is sourced from Yahoo Finance and cached; historical storage may be added later.
SEC Filings
No SEC filings found for this symbol (may be non-US or ticker not in SEC index).
Public Trades for PIRS
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|